Literature DB >> 1321909

Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.

C J Cunliffe1, T J Franklin, N J Hales, G B Hill.   

Abstract

N-Oxaloglycine (3) is an alpha-ketoglutarate (1) analogue that is a competitive inhibitor of prolyl 4-hydroxylase (EC 1.14.11.2). A study of the structure-activity relationships of some other oxalo derivatives shows that substitution on the glycine moiety modulates activity stereoselectively and that if the omega-carboxylate is homologated or replaced by either acylsulfonamides or anilide, then activity is sharply reduced. This sensitivity to these changes is contrasted with the relative insensitivity of another putative alpha-ketoglutarate analogue, pyridine-2,5-dicarboxylic acid (2), and the implication is discussed that compounds of both series are unlikely to bind to prolyl hydroxylase in the same way even though both inhibit the enzyme competitively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321909     DOI: 10.1021/jm00092a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

Review 1.  Cellular oxygen sensing in health and disease.

Authors:  David R Mole; Peter J Ratcliffe
Journal:  Pediatr Nephrol       Date:  2007-10-23       Impact factor: 3.714

Review 2.  Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling.

Authors:  Kelsey G DeFrates; Daniela Franco; Ellen Heber-Katz; Phillip B Messersmith
Journal:  Biomaterials       Date:  2021-01-09       Impact factor: 12.479

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Circadian Clock Interaction with HIF1α Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle.

Authors:  Clara Bien Peek; Daniel C Levine; Jonathan Cedernaes; Akihiko Taguchi; Yumiko Kobayashi; Stacy J Tsai; Nicolle A Bonar; Maureen R McNulty; Kathryn Moynihan Ramsey; Joseph Bass
Journal:  Cell Metab       Date:  2016-10-20       Impact factor: 27.287

Review 5.  Collagen Prolyl 4-Hydroxylase as a Therapeutic Target.

Authors:  James D Vasta; Ronald T Raines
Journal:  J Med Chem       Date:  2018-07-23       Impact factor: 7.446

6.  Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine.

Authors:  Andrew J Leger; Allison Altobelli; Leocadia M Mosquea; Adam J Belanger; Antonius Song; Seng H Cheng; Canwen Jiang; Nelson S Yew
Journal:  J Bone Miner Metab       Date:  2010-03-19       Impact factor: 2.626

Review 7.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

8.  Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation.

Authors:  Mario Thevis; Maxie Kohler; Nils Schlörer; Wilhelm Schänzer
Journal:  J Am Soc Mass Spectrom       Date:  2007-11-09       Impact factor: 3.109

9.  Purification and initial characterization of proline 4-hydroxylase from Streptomyces griseoviridus P8648: a 2-oxoacid, ferrous-dependent dioxygenase involved in etamycin biosynthesis.

Authors:  C C Lawrence; W J Sobey; R A Field; J E Baldwin; C J Schofield
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Renal CD133(+)/CD73(+) progenitors produce erythropoietin under hypoxia and prolyl hydroxylase inhibition.

Authors:  Benedetta Bussolati; Carola Lauritano; Aldo Moggio; Federica Collino; Massimiliano Mazzone; Giovanni Camussi
Journal:  J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.